Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

Hdl Handle:
http://hdl.handle.net/10144/619119
Title:
Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study
Authors:
Bastard, M; Sanchez-Padilla, E; du Cros, P; Khamraev, AK; Parpieva, N; Tillyashaykov, M; Hayrapetyan, A; Kimenye, K; Khurkhumal, S; Dlamini, T; Perez, SF; Telnov, A; Hewison, C; Varaine, F; Bonnet, M
Journal:
PloS ONE
Abstract:
The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic represent a serious threat for reducing the global burden of TB. Although data on HIV-negative DR-TB treatment outcomes are well published, few data on DR-TB outcomes among HIV co-infected people is available despite the great public health importance.
Publisher:
Public Library of Science
Issue Date:
8-Mar-2018
URI:
http://hdl.handle.net/10144/619119
DOI:
10.1371/journal.pone.0193491
PubMed ID:
29518098
Submitted date:
2018-05-03
Language:
en
ISSN:
1932-6203
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorBastard, Men
dc.contributor.authorSanchez-Padilla, Een
dc.contributor.authordu Cros, Pen
dc.contributor.authorKhamraev, AKen
dc.contributor.authorParpieva, Nen
dc.contributor.authorTillyashaykov, Men
dc.contributor.authorHayrapetyan, Aen
dc.contributor.authorKimenye, Ken
dc.contributor.authorKhurkhumal, Sen
dc.contributor.authorDlamini, Ten
dc.contributor.authorPerez, SFen
dc.contributor.authorTelnov, Aen
dc.contributor.authorHewison, Cen
dc.contributor.authorVaraine, Fen
dc.contributor.authorBonnet, Men
dc.date.accessioned2018-05-08T14:24:27Z-
dc.date.available2018-05-08T14:24:27Z-
dc.date.issued2018-03-08-
dc.date.submitted2018-05-03-
dc.identifier.citationOutcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study. 2018, 13 (3):e0193491 PLoS ONEen
dc.identifier.issn1932-6203-
dc.identifier.pmid29518098-
dc.identifier.doi10.1371/journal.pone.0193491-
dc.identifier.urihttp://hdl.handle.net/10144/619119-
dc.description.abstractThe emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic represent a serious threat for reducing the global burden of TB. Although data on HIV-negative DR-TB treatment outcomes are well published, few data on DR-TB outcomes among HIV co-infected people is available despite the great public health importance.en
dc.language.isoenen
dc.publisherPublic Library of Scienceen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen
dc.titleOutcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort studyen
dc.identifier.journalPloS ONEen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.